Pages that link to "Q42628290"
Jump to navigation
Jump to search
The following pages link to Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease (Q42628290):
Displaying 50 items.
- Parkinson's disease: from monogenic forms to genetic susceptibility factors (Q22242870) (← links)
- Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro (Q24311461) (← links)
- Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease (Q24596763) (← links)
- Visual dysfunction in Parkinson's disease (Q26740467) (← links)
- Meta-analysis of risk factors for Parkinson's disease dementia (Q26743404) (← links)
- The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease (Q26744716) (← links)
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies (Q27686837) (← links)
- Alpha-synuclein and tau: teammates in neurodegeneration? (Q28250508) (← links)
- Neurotrophic factors as a therapeutic target for Parkinson's disease (Q28273071) (← links)
- Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage (Q28396892) (← links)
- Genomic determinants of motor and cognitive outcomes in Parkinson's disease (Q28943408) (← links)
- Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database (Q29417106) (← links)
- Parkinson Disease and Dementia (Q30248574) (← links)
- Tau isoform regulation is region- and cell-specific in mouse brain. (Q30493882) (← links)
- Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease. (Q30499875) (← links)
- Biomarkers for dementia and mild cognitive impairment in Parkinson's disease (Q31097119) (← links)
- Visualising disease progression on multiple variables with vector plots and path plots (Q33454017) (← links)
- Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease (Q33475213) (← links)
- Roles of tau protein in health and disease (Q33559303) (← links)
- Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease (Q33636374) (← links)
- LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease (Q33682480) (← links)
- The neurobiological basis of cognitive impairment in Parkinson's disease (Q33724698) (← links)
- Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample. (Q33813336) (← links)
- Biomarkers for cognitive impairment in Parkinson disease (Q33896664) (← links)
- Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse. (Q33899853) (← links)
- The relationships between mild cognitive impairment and phenotype in Parkinson's disease (Q33917203) (← links)
- LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease (Q34108513) (← links)
- Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis (Q34140991) (← links)
- Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study (Q34174901) (← links)
- Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome (Q34234597) (← links)
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? (Q34327102) (← links)
- The genetics of Parkinson disease (Q34604083) (← links)
- A genome-wide linkage screen in the Amish with Parkinson disease points to chromosome 6 (Q34801743) (← links)
- Independent and joint effects of the MAPT and SNCA genes in Parkinson disease (Q34860779) (← links)
- Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON. (Q35045343) (← links)
- Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals (Q35158915) (← links)
- Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease (Q35161892) (← links)
- SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population (Q35859538) (← links)
- Genetic influences on cognitive decline in Parkinson's disease (Q35881786) (← links)
- Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. (Q35938554) (← links)
- The role of tau in the pathological process and clinical expression of Huntington's disease (Q36066666) (← links)
- Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. (Q36206015) (← links)
- The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward (Q36332532) (← links)
- Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease (Q36343417) (← links)
- Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions (Q36389883) (← links)
- Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson’s disease susceptibility? (Q36491685) (← links)
- Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease? (Q36491690) (← links)
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies (Q36653957) (← links)
- Common variants in PARK loci and related genes and Parkinson's disease (Q36711910) (← links)
- An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology (Q36758618) (← links)